Pfizer Inc. (PFE)
28.45
-0.36
(-1.25%)
USD |
NYSE |
Sep 04, 16:00
28.42
-0.03
(-0.11%)
Pre-Market: 20:00
Pfizer Total Return Level : 95.16 for Sept. 4, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 04, 2026 | 95.16 |
| September 03, 2026 | 96.37 |
| September 02, 2026 | 97.07 |
| September 01, 2026 | 95.50 |
| August 31, 2026 | 95.20 |
| August 28, 2026 | 93.52 |
| August 27, 2026 | 93.73 |
| August 26, 2026 | 94.66 |
| August 25, 2026 | 95.57 |
| August 24, 2026 | 93.56 |
| August 21, 2026 | 93.89 |
| August 20, 2026 | 92.96 |
| August 19, 2026 | 94.46 |
| August 18, 2026 | 91.15 |
| August 17, 2026 | 89.88 |
| August 14, 2026 | 89.61 |
| August 13, 2026 | 89.64 |
| August 12, 2026 | 88.01 |
| August 11, 2026 | 89.04 |
| August 10, 2026 | 90.48 |
| August 07, 2026 | 89.51 |
| August 06, 2026 | 87.64 |
| August 05, 2026 | 86.33 |
| August 04, 2026 | 85.00 |
| August 03, 2026 | 83.72 |
| Date | Value |
|---|---|
| July 31, 2026 | 83.66 |
| July 30, 2026 | 83.32 |
| July 29, 2026 | 84.13 |
| July 28, 2026 | 84.46 |
| July 27, 2026 | 82.52 |
| July 24, 2026 | 82.09 |
| July 23, 2026 | 82.22 |
| July 22, 2026 | 81.59 |
| July 21, 2026 | 81.99 |
| July 20, 2026 | 81.36 |
| July 17, 2026 | 82.35 |
| July 16, 2026 | 82.64 |
| July 15, 2026 | 81.59 |
| July 14, 2026 | 79.72 |
| July 13, 2026 | 80.47 |
| July 10, 2026 | 79.46 |
| July 09, 2026 | 79.72 |
| July 08, 2026 | 79.06 |
| July 07, 2026 | 79.13 |
| July 06, 2026 | 77.98 |
| July 02, 2026 | 79.95 |
| July 01, 2026 | 78.50 |
| June 30, 2026 | 79.16 |
| June 29, 2026 | 80.11 |
| June 26, 2026 | 79.85 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Johnson & Johnson | 656.76 |
| Eli Lilly & Co. | 3036.85 |
| Merck & Co., Inc. | 462.15 |
| Bristol Myers Squibb Co. | 252.81 |
| Viatris, Inc. | 21.13 |